The 8th IDIBELL sLHam of scientists will vindicate the role and presence of women in research

The event will take place on Thursday, February 6, at the Barradas Auditorium in L’Hospitalet and will commemorate the International Day of Women and Girls in Science.
A multifaceted look at the role of women in biomedical research will be the focus of this year’s sLHam, which will talk about women as researchers and as researched.
In its 8th edition, the sLHam will have two sessions, a morning session for students and an afternoon session for the general public.

The 8th IDIBELL sLHam of scientists will vindicate the role and presence of women in research Read More »

A new triple combination of inhibitors based on precision medicine emerges as a potential new treatment for Malignant Peripheral Nerve Sheath Tumors

A multicenter collaboration leaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a potential new treatment for an aggressive sarcoma arising in the nerves. The findings have been published in the journal Clinical Cancer Research.

A new triple combination of inhibitors based on precision medicine emerges as a potential new treatment for Malignant Peripheral Nerve Sheath Tumors Read More »

Multicentre study reaffirms need for vaccination in adults to protect against Invasive Pneumococcal Disease

The study underscores the importance of increasing vaccination in adults to prevent invasive pneumococcal disease, especially in risk groups (older adults and/or those with comorbidities).
There is a need to continue developing and improving pneumococcal vaccines to expand their coverage, given the great capacity of these pathogens to adapt.

Multicentre study reaffirms need for vaccination in adults to protect against Invasive Pneumococcal Disease Read More »

Dr. Fernando Fernández Aranda and Dr. Esteve Fernández, distinguished with ICREA Academia grants to promote research

Two IDIBELL researchers receive financial support to consolidate and enhance the internationalization of their research

Dr. Fernando Fernández Aranda and Dr. Esteve Fernández, distinguished with ICREA Academia grants to promote research Read More »

New perspectives on prostate cancer: the identification of dietary and microbial metabolites could be key in prevention

This large-scale nutrimetabolomic analysis, one of the most extensive to date, underscores the relevance of dietary factors and the gut microbiome in prostate cancer risk.
The study has been led by the Bellvitge Biomedical Research Institute (IDIBELL), the University of Barcelona and the CIBER on Frailty and Healthy Ageing (CIBERFES).

New perspectives on prostate cancer: the identification of dietary and microbial metabolites could be key in prevention Read More »

A multicenter clinical trial has evaluated the efficacy and safety of extended antibiotic infusion in febrile neutropenia

A Bellvitge research team has conducted a randomized clinical trial in hematological patients with febrile neutropenia to assess the efficacy of extended infusion of beta-lactam antibiotics

The results show that extended perfusion may be useful in combating some infections, but do not support the introduction of this technique into daily clinical practice for the empirical treatment of febrile neutropenia.

A multicenter clinical trial has evaluated the efficacy and safety of extended antibiotic infusion in febrile neutropenia Read More »

IDIBELL, Bellvitge Hospital and the Josep Carreras Institute discover a key mechanism in the recovery of kidney transplant function

They have described a cause why kidney progenitor cells sometimes can’t repair damaged tissues
The study has been published in the American Journal of Transplantation, the journal with the highest impact on transplantation

IDIBELL, Bellvitge Hospital and the Josep Carreras Institute discover a key mechanism in the recovery of kidney transplant function Read More »

Scroll to Top